Skip to main content
    I

    IRIDEX Corporation (IRIX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.69
    -0.00 (-0.32%)

    Market Cap: $12.12M

    Last updated: Nov 17, 2026 at 10:43 AM ET

    IRIDEX Corporation (IRIX) Earnings: Report Dates and Results

    Updated Aug 18, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    IRIDEX (IRIX) is confirmed to report earnings on Nov 17, 2026, after the close. In the quarter ended Jun 30, 2026, IRIDEX reported EPS of -$0.07, below the -$0.01 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    56%(22/39)
    Avg Surprise
    -38.77%

    Upcoming Estimates

    Reports Nov 17, 2026 after closePeriod ending Sep 30, 2026
    EPS Consensus-$0.04
    Range-$0.04 - -$0.04
    1 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.02-100.0%
    60d ago-$0.02-100.0%
    30d ago-$0.02-100.0%
    7d ago-$0.02-100.0%
    Current-$0.04
    Revenue Consensus
    $12.64M
    Range$12.64M - $12.64M
    1 analysts
    Reports Mar 24, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.02
    Range$0.02 - $0.02
    3 analysts
    Revenue Consensus
    $15.82M
    Range$15.20M - $16.29M
    3 analysts

    Next Report

    IRIX has a confirmed report date of Nov 17, 2026, after the close.

    IRIX Earnings Call

    The latest IRIX earnings call transcript on file is labeled 2026Q2.

    Read the 2026Q2 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, IRIX beat 22, missed 16 and matched 2. Revenue for the quarter ended Jun 30, 2026 was $12.57M, down 7.4% from $13.57M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Jun 30, 2026-$0.07-$0.01-$0.01 - -$0.01-600.00%MissN/A11 up, 0 downAug 18, 2026$12.57M
    Mar 31, 2026-$0.03-$0.07-$0.07 - -$0.07+57.14%BeatN/A10 up, 1 downMay 19, 2026$11.80M
    Dec 31, 2025-$0.01-$0.02N/A+46.50%BeatN/AN/AN/AMar 26, 2026$14.72M
    Sep 30, 2025-$0.09-$0.06N/A-50.00%MissN/AN/AN/ANov 11, 2025$12.48M
    Jun 30, 2025-$0.06-$0.09N/A+33.33%BeatN/AN/AN/AAug 12, 2025$13.57M
    Mar 31, 2025-$0.10-$0.12N/A+16.00%BeatN/AN/A1 up, 0 downMay 13, 2025$11.90M
    Dec 31, 2024-$0.05-$0.05N/A-0.20%MissN/AN/A1 up, 0 downMar 27, 2025$12.70M
    Sep 30, 2024-$0.12-$0.09N/A-33.33%MissN/AN/A1 up, 0 downNov 12, 2024$11.58M
    Jun 30, 2024-$0.16-$0.12-$0.12 - -$0.12-33.33%MissN/A10 up, 0 downAug 8, 2024$12.63M
    Mar 31, 2024-$0.21-$0.12-$0.12 - -$0.12-75.00%MissN/A10 up, 0 downMay 14, 2024$11.76M
    Dec 31, 2023-$0.18-$0.05-$0.05 - -$0.05-260.00%MissN/A10 up, 0 downMar 26, 2024$12.46M
    Sep 30, 2023-$0.11-$0.12-$0.14 - -$0.11+8.33%BeatN/A20 up, 0 downNov 14, 2023$12.85M
    Jun 30, 2023-$0.17-$0.11-$0.12 - -$0.10-54.55%MissN/A20 up, 0 downAug 10, 2023$12.86M
    Mar 31, 2023-$0.13-$0.12-$0.13 - -$0.11-8.33%MissN/A20 up, 0 downMay 11, 2023$13.71M
    Dec 31, 2022-$0.07-$0.11-$0.11 - -$0.11+36.36%BeatN/A20 up, 0 downMar 9, 2023$15.20M
    Sep 30, 2022-$0.11-$0.14-$0.16 - -$0.13+21.43%BeatN/A20 up, 0 downNov 10, 2022$14.63M
    Jun 30, 2022-$0.14-$0.15-$0.17 - -$0.14+6.67%Beat-255.6%20 up, 0 downAug 15, 2022$13.76M
    Mar 31, 2022-$0.15-$0.16-$0.18 - -$0.14+6.25%BeatN/A20 up, 0 downMay 12, 2022$13.39M
    Dec 31, 2021-$0.15-$0.11-$0.11 - -$0.11-36.36%MissN/A2N/AMar 10, 2022$15.25M
    Sep 30, 2021-$0.14-$0.14-$0.16 - -$0.130.00%In lineN/A2N/ANov 11, 2021$13.26M
    Jun 30, 2021$0.09-$0.15-$0.16 - -$0.15+160.00%BeatN/A2N/AAug 12, 2021$13.43M
    Mar 31, 2021-$0.14-$0.14-$0.15 - -$0.130.00%In lineN/A2N/AMay 11, 2021$11.96M
    Dec 31, 2020-$0.01-$0.10-$0.17 - -$0.04+90.00%BeatN/A2N/AMar 22, 2021$12.30M
    Sep 30, 2020-$0.12-$0.17-$0.18 - -$0.17+29.41%BeatN/A2N/ANov 9, 2020$8.80M
    Jun 30, 2020-$0.20-$0.22-$0.24 - -$0.21+9.09%BeatN/A2N/AAug 6, 2020$6.22M
    Mar 31, 2020-$0.12-$0.19-$0.19 - -$0.14+36.84%BeatN/A2N/AMay 11, 2020$9.02M
    Dec 31, 2019-$0.11-$0.15-$0.17 - -$0.14+26.67%BeatN/A2N/AMar 12, 2020$11.76M
    Sep 30, 2019-$0.13-$0.19-$0.19 - -$0.16+31.58%BeatN/A2N/ANov 7, 2019$10.66M
    Jun 30, 2019-$0.18-$0.22-$0.22 - -$0.22+18.18%BeatN/A2N/AAug 6, 2019$10.43M
    Mar 31, 2019-$0.22-$0.24-$0.25 - -$0.23+8.33%BeatN/A2N/AMay 2, 2019$10.60M
    Dec 31, 2018-$0.21-$0.24-$0.25 - -$0.24+12.50%BeatN/A2N/AMar 5, 2019$11.47M
    Sep 30, 2018-$0.26-$0.28-$0.29 - -$0.28+7.14%BeatN/A2N/ANov 1, 2018$11.32M
    Jun 30, 2018-$0.28-$0.32-$0.32 - -$0.32+12.50%BeatN/A1N/AAug 2, 2018$10.30M
    Mar 31, 2018-$0.31-$0.33-$0.33 - -$0.33+6.06%BeatN/A1N/AMay 3, 2018$9.51M
    Dec 31, 2017-$0.44-$0.27-$0.27 - -$0.27-62.96%MissN/A1N/AMar 8, 2018$10.24M
    Sep 30, 2017-$0.28-$0.15-$0.28 - -$0.15-86.67%MissN/A2N/ANov 2, 2017$10.87M
    Jun 30, 2017-$0.24-$0.12-$0.18 - -$0.06-100.00%Miss-2500.0%2N/AAug 3, 2017$10.00M
    Mar 31, 2017-$0.16-$0.12N/A-33.33%Miss-1700.0%N/AN/AMay 3, 2017$10.48M
    Dec 31, 2016-$1.03-$0.12N/A-758.33%Miss-2675.0%N/AN/AMar 8, 2017$12.53M
    Sep 30, 2016-$0.07-$0.03N/A-133.33%Miss-275.0%N/AN/ANov 3, 2016$9.79M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.26, after -$0.54 the year before. It was -$1.08 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.26N/A
    Dec 31, 2024-$0.54N/A
    Dec 31, 2023-$0.59N/A
    Dec 31, 2022-$0.47N/A
    Dec 31, 2021-$0.34N/A
    Dec 31, 2020-$0.45N/A
    Dec 31, 2019-$0.64N/A
    Dec 31, 2018-$1.06N/A
    Dec 31, 2017-$1.12N/A
    Dec 31, 2016-$1.08N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q2 for the period ended Jun 30, 2026, runs about 3,500 words across 5 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q2Jun 30, 20263,5135
    2026Q1Mar 31, 20263,7565
    2025Q4Dec 31, 20253,4255
    2025Q3Sep 30, 20252,1324
    2025Q2Jun 30, 20252,0844
    2025Q1Mar 31, 20252,3544
    2024Q3Sep 30, 20242,6774
    2024Q2Jun 30, 20242,5865

    2026Q2 Earnings Call

    Opening remarks

    Trip Taylor Investor Relations Thank you, operator. Thank you all for joining us this afternoon. With me on today's call are Patrick Mercer, IRIDEX's Chief Executive Officer, and Romeo R. Dizon, the company's Chief Financial Officer. Earlier today, IRIDEX issued a press release detailing our financial results for the quarter ended 07/04/2026, which is posted to the Investors section of our website. Before we begin, I would like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements made during this call that are not statements of historical fact, including, but not limited to, statements concerning our strategic goals and priorities, product development matters, sales trends, and the markets in which we operate, are forward-looking. All forward-looking statements are based upon our current estimates and various assumptions. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. Accordingly, you should not place reliance on these statements. For a discussion of the risks and uncertainties associated with our business, please see the most recent Form 10-K and Form 10-Q filings with the SEC. IRIDEX disclaims any intention or obligation, except as required by law, to update or revise any financial projections or forward-looking statements, whether because of new information, future events, or otherwise. This conference call contains time-sensitive information and is accurate only as of the live broadcast today, August 18, 2026. With that, I will pass the call to Patrick.

    Patrick Mercer Chief Executive Officer Good afternoon, everyone, and thank you for joining us for our second quarter call. If there is one message I want to leave you with today, it is that IRIDEX has reached an important inflection point in its financial profile. We generated positive cash flow in the second quarter demonstrating the meaningful progress we have made over the past two years to fundamentally transform our cost structure, strengthen working capital management and create a more disciplined and sustainable business. As part of our activity to further improve the efficiency of the business, this month we began the process of relocating our headquarters. This is a long-anticipated cost-cutting step and an important part of our broader effort to optimize our cost structure, improve operational efficiency, and align our infrastructure with the business we are building for the future. The headquarters move will require a new registration process and managing global registration blackout periods in order to secure our international supply chain and protect top-line distributor revenue streams.

    Frequently Asked Questions About IRIX

    When is IRIDEX's next earnings date?

    IRIDEX's next earnings report is confirmed for Nov 17, 2026, after the close.

    Did IRIX beat earnings estimates last quarter?

    No. IRIDEX reported EPS of -$0.07 for the quarter ended Jun 30, 2026, below the -$0.01 estimate by 600.00%.

    What EPS do analysts expect from IRIX next quarter?

    The consensus EPS estimate for IRIDEX for the quarter ended Sep 30, 2026 is -$0.04 from 1 analyst, with estimates from -$0.04 to -$0.04.

    How often does IRIX beat earnings estimates?

    IRIDEX beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -66.32%.

    Does IRIX report before or after the market opens?

    IRIDEX is confirmed to report on Nov 17, 2026, after the market closes.